VBS
VECTUS BIO FPO [VBS]
Healthcare · ASX Small Cap
$0.1300 -3.7%
Updated 2026-03-02 · Scores refresh every scan
⚠ Funding Risk — Cash runway under 4 quarters. Capital raise or funding may be required.
Appeared in 2 consecutive scans→ Score +4First seen: 2026-02-25
Score Breakdown
Technical45
Catalyst50
Sentiment50
Fundamental15
Momentum62
Risk Gate40
Active Signals
Bullish Signals
- RSI approaching oversold
- Stochastic oversold
- Volatility contracting (breakout setup)
- Above 200-day MA (long-term uptrend)
- Critical cash runway (1.6 quarters)
- 4C filed 2026-01-30
- Very high P/S ratio (80.2x)
- Revenue in sharp decline (-99%)
- Micro-cap ($5-20M) - high risk
- CANSLIM S: Tight float (41%)
- Strong 12-1 momentum (+53%)
- Liquidity risk: 8 zero-volume days in last 20
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
Risk Signals
- MACD momentum weakening
- Death cross (bearish)
- Negative 5-day momentum (-7.1%)
- VPT distribution divergence (bearish)
- Piotroski F-Score weak (3/9)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
- Revenue momentum declining (-99%)
Recent Catalysts
NONE Half Year Report & Appendix 4D
LOW Quarterly Activities & Appendix 4C Cash Flow Reports
Recent ASX Announcements
| 2026-02-26 | Half Year Report & Appendix 4D PRICE SENSITIVE |
| 2026-01-30 | Quarterly Activities & Appendix 4C Cash Flow Reports PRICE SENSITIVE |
Key Metrics
$7.2M
Market Cap
39K
Avg Volume
1.9x
Vol Ratio
$0.04 — $0.46
52-Week Range
N/A
Short Interest
2 qtrs
Cash Runway
N/A
ROE
N/A
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | pass | Float: 41% |
| L | Leader vs Laggard | laggard | RS: -5 |
| I | Institutional Sponsorship | weak | Inst: 8% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #107 of 119 · Sector avg: 51
View all Healthcare signals →